CURRENT PHARMACY
CE TOPICS

CE PRN® Pharmacy Continuing Education Courses 2017

Current participants: Click on program ID# to read or download each lesson.
Click on the Buy button to purchase an individual lesson.
In order to obtain CE credit, you must purchase an individual lesson or the entire year course.

"Pharmacy Law Update" 707-000-17-011-H03-P (for Pharmacists); 707-000-17-011-H03-T (for Technicians) November/December (3.0 contact hours)

This is the annual double lesson for November & December. Additionally, it provides 3.0 (0.3 CEUs) contact hours of credit, and fulfills the pharmacy law CE requirement in most states. (Check your Board of Pharmacy requirements for specifics). We focus on and summarize 14 recent legal cases in which aspects of pharmacy practice have been addressed by a court of law. Each case scenario presents a factual situation and a legal analysis by the court of that situation. Significant practicebased conclusions can be drawn from the result of each case. The goal is to provide understanding of judicial expectations of pharmacists and technicians.buy-button

"Update - Safe Handling of Hazardous Waste" 707-000-17-010-H01-P (for Pharmacists); 707-000-17-010-H01-T (for Technicians) October (1.25 contact hours)

In this lesson, we will focus on the safe handling of hazardous drugs in the hospital and in the community pharmacy setting. The goal is to review the requirements of USP Chapter <800>, which will take effect July 1, 2018.buy-button

"Review & Update: Cystic Fibrosis" 707-000-17-009-H01-P (for Pharmacists); 707-000-17-009-H01-T (for Technicians) September (1.25 contact hours)

Cystic fibrosis (CF) is a chronic, life-threatening autosomal, recessive (genetic) disorder that is inherited from both parents whose genes have undergone genetic changes (mutations) in the Cystic Fibrosis Membrane Conductance Regulator (CFTR) protein which is encoded by the CFTR gene. This is one of a number of topics that we review every few years common adverse effects, contraindications and key counseling points.buy-button

"Part 2: New Drugs Approved in 2016" 707-000-17-008-H01-P (for Pharmacists); 707-000-17-008-H01-T (for Technicians) August (1.25 contact hours)

The FDA approved only 22 new molecular entities (NME) in 2016. In this lesson, and the previous one, we focus on some of the newer agents that are of interest to pharmacy practitioners. Information is provided that includes dosing guidelines, common adverse effects, contraindications and key counseling points.buy-button

"New Drugs Approved in 2016" 707-000-17-007-H01-P (for Pharmacists); 07-000-17-007-H01-T (for Technicians) July (1.25 contact hours)

The FDA approved only 22 new molecular entities (NME) in 2016. In the next two lessons, we focus on some of the newer agents that are of interest to pharmacy practitioners. Information is provided that includes dosing guidelines, common adverse effects, contraindications and key counseling points.buy-button

"Update: C. diff." 707-000-17-006-H01-P (for Pharmacists); 707-000-17-006-H01-T (for Technicians) June (1.25 contact hours)

Clostridium difficile infection (CDI) remains a leading source of morbidity and mortality among hospitalized patients, since its original description as the cause of pseudomembranous colitis This lesson reviews the epidemiology, diagnosis and treatment of C. difficile infections.buy-button

"Parkinson’s Disease" 707-000-17-005-H01-P (for Pharmacists); 707-000-17-005-H01-T (for Technicians) May (1.25 contact hours)

Parkinson’s disease (PD) is a chronic, progressive, degenerative neurologic disease that affects body movement, muscle control and balance. It is considered the most common movement disorder. It is a topic that we revisit every few years because it is the third most common neurologic disease (10 in 1000), and new therapies are often coming into existence.buy-button

"MEDICATION ERRORS PREVENTION—PHARMACY UPDATE" 707-000-17-003-H05-P (for Pharmacists); 07-000-17-003-H05-T (for Technicians) March and April (3.0 contact hours)

This is our biannual lesson on ‘Medication Errors.’ Errors cannot be eliminated, but they can be reduced and minimized. The general goal of this lesson is to review the concepts related to medication error reduction. This is a knowledge – based CPE activity. We shall include a situation that resulted in criminal charges and conviction against a pharmacist as a result of an error. Medication error reduction can, hopefully, be achieved with a program of Continuous Quality Improvement (CQI). We shall discuss this also.buy-button

"Stroke Therapy" 707-000-17-002-H01-P (for Pharmacists); 707-000-17-002-H01-T (for Technicians) February (1.25 contact hours)

The medical term for stroke is cerebrovascular accident (CVA). It involves the sudden death of brain cells due to deprivation of oxygen and nutrients and is caused by obstruction of blood flow in an artery or rupture of an artery in the brain. Pharmacists may not be actively involved with patient care regarding stroke; however, it IS an area where we can provide invaluable service by counseling patients and their families.buy-button

"Seizure Disorders" 707-000-17-001-H01-P (for Pharmacists); 707-000-17-001-H01-T (for Technicians) January (1.25 contact hours)

Seizure disorders are a chronic group of neurological diseases characterized by episodes of abnormal, unorganized, electrical activity that takes place in the cortical gray matter of the brain and temporarily disrupt and interfere with normal charges in the brain. The primary goal of seizure disorder treatment is to achieve a seizure-free patient. We update this topic often because it’s so important.buy-button

 

 

logo CPE Monitor